Cargando…

Olaparib-Induced Purpuric Drug Eruption in a Patient with Castration-Resistant Prostate Cancer

Olaparib is recently approved as an anti-tumor agent for several cancers, including castration-resistant prostate cancer, which inhibits poly (adenosine diphosphate-ribose) polymerase, a DNA repair factor. Since olaparib is a newly approved drug, there are few reports of skin disorders that may be t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sekine, Mana, Terui, Hitoshi, Fujimura, Taku, Asano, Yoshihide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294207/ https://www.ncbi.nlm.nih.gov/pubmed/37384205 http://dx.doi.org/10.1159/000530981

Ejemplares similares

Inflammatory and Purpuric Eruptions
por: Baselga, Eulalia, et al.
Publicado: (2008)

Purpuric eruption in a child
por: Bou-Prieto, Alfredo, et al.
Publicado: (2019)

Purpuric eruption of the breasts, abdomen, thighs, and buttocks
por: Masehi-Lano, Jacqueline J., et al.
Publicado: (2022)

Palpable purpuric eruption mimicking vasculitis following avapritinib
por: Mohammed, Taha Osman, et al.
Publicado: (2022)

Unusual purpuric eruption in a child
por: Lin, Jaimie, et al.
Publicado: (2021)

Generalized papular-purpuric eruption due to Solenopsis fugax bites
por: Romita, Paolo, et al.
Publicado: (2018)

Olaparib vs Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer
por: Wallis, Christopher J. D., et al.
Publicado: (2021)

Purpuric Eruption: Sign of Infected Bypass Graft
por: Ferreira, Joana, et al.
Publicado: (2018)

Erlotinib-induced purpuric papulopustular eruption treated with pulsed azithromycin
por: Akoglu, Gulsen, et al.
Publicado: (2016)

Purpuric Drug Eruption in a Patient with Atopic Dermatitis Treated with Dupilumab
por: WANG, Mingxia, et al.
Publicado: (2022)

Expression of MUS81 Mediates the Sensitivity of Castration-Resistant Prostate Cancer to Olaparib
por: Gong, Lifeng, et al.
Publicado: (2022)

Diffuse purpuric eruption in a patient with acute myeloid leukemia
por: Momin, Zoha K., et al.
Publicado: (2023)

Epidermal growth factor receptor (EGFR) inhibitor induced purpuric drug eruption: Three case reports
por: Fang, Szu-Yun, et al.
Publicado: (2019)

Response to olaparib in metastatic castration-resistant prostate cancer with germline BRCA2 mutation: a case report
por: Ma, Yi, et al.
Publicado: (2018)

Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer
por: Su, Dan, et al.
Publicado: (2021)

Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer
por: Fallara, Giuseppe, et al.
Publicado: (2023)

The Antimicrobial Peptide Cathelicidin Exerts Immunomodulatory Effects via Scavenger Receptors
por: Amagai, Ryo, et al.
Publicado: (2023)

Role of Olaparib in the Management of Metastatic Castration-Resistant Prostate Cancer: A Japanese Clinician’s Perspective
por: Matsumoto, Takashi, et al.
Publicado: (2022)

Comparative efficacy of olaparib in combination with or without novel antiandrogens for treating metastatic castration-resistant prostate cancer
por: Chen, Xiangyu, et al.
Publicado: (2023)

Biologics for Reducing Cardiovascular Risk in Psoriasis Patients
por: Terui, Hitoshi, et al.
Publicado: (2023)

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
por: Karzai, Fatima, et al.
Publicado: (2018)

Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection
por: LeVee, Alexis, et al.
Publicado: (2021)

Cost-effectiveness of olaparib, a PARP inhibitor, for patients with metastatic castration-resistant prostate cancer in China and United States
por: Xu, Chenxia, et al.
Publicado: (2022)

Lamotrigine-induced DRESS with purpuric lesions in the oral mucosa
por: Bozca, Burçin Cansu, et al.
Publicado: (2020)

A case of pembrolizumab-induced pigmented purpuric dermatosis
por: Oyeku, Oluwaseun J., et al.
Publicado: (2023)

Distinct purpuric lesions in patients with dermatomyositis
por: Cho, Sung Kyung, et al.
Publicado: (2021)

Lichenoid drug eruption associated with Bendamustine
por: Kusano, Y, et al.
Publicado: (2016)

Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection [Corrigendum]
Publicado: (2021)

Olaparib outcomes in metastatic castration-resistant prostate cancer: First real-world experience in safety and efficacy from the Chinese mainland
por: Pan, Jian, et al.
Publicado: (2022)

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984
por: Kim, Joseph W., et al.
Publicado: (2023)

Addition of Olaparib to the New Hormonal Agent Regimen for Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
por: Warli, Syah Mirsya, et al.
Publicado: (2023)

In Purpur geboren : Roman /
por: Passuth, László
Publicado: (1965)

Quantitative Analysis of Immune-Reactive Cells among Leukocytes Is Useful for the Diagnosis of Drug Eruptions Caused by Bexarotene
por: Chiba, Hiromu, et al.
Publicado: (2022)

Ureter metastatic castration-resistant prostate cancer: a case report
por: Tsutsumi, Sohgo, et al.
Publicado: (2017)

Serum CCL22 Increased in Advanced Melanoma Patients with Liver Metastases: Report of 5 Cases
por: Ohuchi, Kentaro, et al.
Publicado: (2022)

Cutaneous sarcoidosis mimicking pigmented purpuric dermatosis
por: Sauvageau, Andrew P., et al.
Publicado: (2022)

Psoriasiform Drug Eruption Caused by Abatacept: Immunohistochemical Investigation of STAT Signaling
por: Tanita, Kayo, et al.
Publicado: (2015)

Naltrexone‐induced drug eruption
por: Heck, Johannes, et al.
Publicado: (2020)

Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma
por: Fujimura, Taku, et al.
Publicado: (2022)

Localized Pustular Purpuric Eruption Associated with Propionic Acid NSAIDs: Acute Localized Exanthematous Pustulosis Accompanied with Leukocytoclastic Vasculitis
por: Baba, Yuko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hvtvn4og8d8n0389b6rnlcfkck